How to reach us: Austria, Czech Republic, France, Germany, Italy, Poland, Spain, Switzerland, Turkey and Great Britain Business description MagForce AG is a leading medical device company in the field of nanomedicine focused on oncology. The Group's proprietary NanoTherm® therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator® are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan, and NanoActivator are trademarks of MagForce AG in selected countries. Initial listing 20.09.2007 Accounting standards German Commercial Code ("HGB") Fiscal year end December 31 Executive Board Dr. Ben J. Lipps, Christian von Volkmann Supervisory Board Norbert Neef (Chairman), Klemens Hallmann, Aron Weaver Registered Office Max-Planck-Str 3, 12489 Berlin, Germany Trading Information ISIN DE000A0HGQF5 Stock Exchange Xetra/Frankfurt German Securities Identification Number (WKN) A0HGQF Ticker Symbol MF6 Market Segment Scale Stock Class No-par-value shares Share Capital 27,640,274 Euro Total Number of Shares 27,640,274 shares Specialist Steubing AG Applying & Supervising Capital Markets Partner, Designated Sponsor Hauck & Aufhäuser Yes, I agree to the processing and use of my personal data in accordance with the Privacy Policy for the purpose of contacting. This website uses Google Analytics to improve future content. Please click here to set an opt‑out‑Cookie if you do not want Google Analytics to track your browsing habits. OK Important Pages Our Therapy For Patients Financial Reports Contact News & Events 05.11.21 MagForce AG: MagForce USA, Inc. has Received FDA’s Approval to Proceed with Stage 2B with the Final Protocol of the Pivotal U.S. Study for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System © 2021 MagForce AG, The Nanomedicine Company Privacy Policy Imprint